| Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target KG Arun, CS Sharanya, J Abhithaj, D Francis, C Sadasivan Journal of Biomolecular Structure and Dynamics 39 (13), 4647-4658, 2021 | 57 | 2021 |
| Compounds of Citrus medica and Zingiber officinale for COVID-19 inhibition: in silico evidence for cues from Ayurveda M Haridas, V Sasidhar, P Nath, J Abhithaj, A Sabu, P Rammanohar Future journal of pharmaceutical sciences 7 (1), 1-9, 2021 | 35 | 2021 |
| Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with Mpro. A J, D Francis, EJ Variyar Journal of Biomolecular Structure & Dynamics, 1-12, 2020 | 12* | 2020 |
| Drug repurposing to identify therapeutics against COVID 19 with SARS-Cov-2 spike glycoprotein and main protease as targets: an in silico study CS Sharanya, J Abhithaj, C Sadasivan | 7 | 2020 |
| Biochemical and computational insights of adenosine deaminase inhibition by Epigallocatechin gallate KG Arun, CS Sharanya, J Abhithaj, C Sadasivan Computational Biology and Chemistry 83, 107111, 2019 | 4 | 2019 |
| Repurposing Simeprevir, Calpain Inhibitor IV and a Cathepsin F Inhibitor Against SARS-CoV-2: A Study Using in Silico Pharmacophore Modeling and Docking Methods A J, A G, D Francis, S CS, J Variyar ChemRxiv, 2020 | 3* | 2020 |
| Isozymes inhibited by active site blocking: versatility of calcium indifferent hesperidin binding to phospholipase A2 and its significance J Abhithaj, KG Arun, CS Sharanya, M Haridas, E Jayadevi Variyar Journal of Receptors and Signal Transduction 39 (1), 60-66, 2019 | 2 | 2019 |
| In silico and in vitro validation of some benzimidazole derivatives as adenosine deaminase inhibitors A Kumar G, S CS Indian Journal of Chemistry-Section B (IJC-B) 59 (8), 1175-1182, 2020 | 1 | 2020 |
| Drug repurposing for COVID-19 from FDA approved and experiment stage drugs by in silico methods with SARS CoV-2 spike protein CS Sharanya, J Abhithaj, A Sabu, H Madathilkovilakathu | 1 | 2020 |
| Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening and molecular docking with main protease as the target CS Sharanya, J Abhithaj, D Francis, C Sadasivan | 1 | 2020 |
| Repurposing of Streptomyces antibiotics as adenosine deaminase inhibitors by pharmacophore modeling, docking, molecular dynamics, and in vitro studies KG Arun, CS Sharanya, J Abhithaj, C Sadasivan Journal of Receptors and Signal Transduction 40 (1), 77-88, 2020 | 1 | 2020 |
| COVID-19 Omicron variant-inhibitory in silico evidence for phytocompounds of an ancient Ayurvedic formulation CS Sharanya, J Abhitaj, A Sabu, M Haridas | | 2022 |
| Drug Repurposing Against SARS-CoV-2 Using E-Pharmacophore Based Virtual Screening and Molecular Docking with Main Protease as the Target J Abhithaj, F Dileep, C Sadasivan | | 2020 |
| Drug Repurposing to Identify Therapeutics Against COVID 19 with SARS-Cov-2 Spike Glycoprotein and Main Protease as Targets: An in Silico Study J Abhithaj, C Sadasivan | | 2020 |
| Computational Studies on Structural Basis of Isoniazid Resistance in Tuberculosis V Rajasekharan, J Abhithaj, G Renganayaki, V Thomas Prospects in Bioscience: Addressing the Issues, 151-157, 2012 | | 2012 |
| A tale of two medicinal plants: A comparative study of medicinal bioactivity of homoeopathic tinctures of Coleus aromaticus and Coleus zeylanicus T Shikha Ramesh, J Abhithaj, M Kiran, CS Sharanya | | |
Sharanya CSResearch Scholar, Kannur UniversityVerified email at kannuruniv.ac.in
